DAFTAR PUSTAKA

1. Kantor PF, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, et

al. Presentation, diagnosis, and medical management of heart failure in
children: Canadian Cardiovascular Society Guidelines. Canadian Journal
of Cardiology. 2013; 29: p1535-1552.

2. Masarone D, Valente F, Rubino M, Vastarella R, Gravino R, Rea A, et al.

Pediatric Heart Failure: A Practical Guide to Diagnosis and Management.
Pediatrics and Neonatology, 2017; 58: 303-312.

3. Kirk R. Dipchand AI, Rosenthal DN, Addonizio L, Burch M, Chrisant M,

et al. The International Society for Heart and Lung Transplantation
Guidelines for the management of pediatric heart failure: Executive
summary. The Journal of Heart and Lung Transplantation, 2014; 33(9):
888-909.

4. Shaddy RE, George AT, Jaecklin T, Lochlainn EN, Thakur L. Agrawal R.

Systematic Literature Review on the Incidence and Prevalence of Heart
Failure in Children and Adolescents. Pediatric Cardiology, 2018; 39: 415–
436.

5. Yuan S-H. Cardiomyopathy in the pediatric patients. Pediatrics and

Neonatology, 2018; 59: 120-128.

6. Bhowmik E, De AK Mukherjee S. Etiological Spectrum of Heart Failure

in Pediatric Population. Indian Journal of Pediatrics, 2015; 82(5): 482.

7. Ramakrishnan S. Pediatric Heart Failure in the Developing World. Rev

Recent Clin Trials. 2014; 9 (2): 86-90.

8. Mandriago E. Silberbach S. Heart Failure in Infants and Children.

Pediatrics in Review, 2010; 31(1): 4-11.

9. New York Heart Association (NYHA) Functional Class. Adapted from

American Heart Association Medical/Scientific Statement. 1994 revisions
to classification of functional capacity and objective assessment of patients
with diseases of the heart. Circulation, 1994; 90: 644–645.
10. Ross, R.D., Daniels, S.R., Schwartz, D.C., et al. “Ross Classification”
data, from Plasma norepinephrine levels in infants and children with
congestive heart failure. Am. J. Cardiol., 1987; 59: 911–914.

11. Das RR, Panda SS, Panda M, Naik SS. Congestive Cardiac Failure in
Children: An Update on Patho-physiology and Management. Cardiol
Pharmacol, 2014; 3: 122.

12. Knudson JD, Cabrera AG. The Pathophysiology of Heart Failure in

Children: The Basics. Current Cardiology Reviews, 2016; 12: 99-103.

13. Hsu DT, Pearson GD. Heart Failure in Children, Part I: History, Etiology,
and Pathophysiology. Circulation Heart Failure. 2009; 2: 63-70.

14. Jayaprasad N. Heart failure in children. Heart Views, 2016; 17: 92-9.

15. Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y, Frobel-Mercier AK. Beta-

blockers for congestive heart failure in children (Review). Cochrane
Database of Systematic Reviews, 2016; Issue 1. Art. No.: CD007037.

16. Hafiz E, Khalil E, Dogan OF. The Management of Pediatric Heart Failure:
Current State and Future Managements. International Journal of Surgery
Research and Practice, 2018; 5(2): 074.

17. Jain S, Vaidyanathan B. Digoxin in management of heart failure in

children: shoud it be discontinued or relegated to the history books?
Annals of Pediatric Cardiology, 2009; 2(2): 149-142.

18. da Cruz EM, Ivy Dunbar, Jagger J (eds). Pediatric and congenital
cardiology, cardiac surgery and intensive care. London: Springer-Verlag,
2014.

19. James H. Moller, Julien I. E. Hoffman. Pediatric cardiovascular medicine.

– 2nd ed. UK: Blackwell Publishing, 2012.

20. Rossano JW, Jang GY. Pediatric Heart Failure: Current State and Future
Possibilities. Korean Circulation Journal, 2015; 45(1): 1-8.